Potential for repurposing oral hypertension/diabetes drugs to decrease asthma risk in obesity. Sood A, Qualls C, Murata A, Kroth PJ, et al. J Asthma 2022 Jul 7:1-12. doi: 10.1080/02770903.2022.2097919.

Read + Share

Amedeo Smart

Independent Medical Education

Sood A, Qualls C, Murata A, Kroth PJ, et al. Potential for repurposing oral hypertension/diabetes drugs to decrease asthma risk in obesity. J Asthma 2022 Jul 7:1-12. doi: 10.1080/02770903.2022.2097919.
PMID: 35796615